NSCLC and the alternative pathway of NF-kB: Uncovering an unknown relation

Virchows Archiv

Volumn 460, Issue 5, 2012, Pages 515-523

  Dimitrakopoulos, Fotinos Ioannis D ^a   Antonacopoulou, Anna G ^a   Kottorou, Anastasia ^a   Vlotinou, Helen ^b   Panagopoulos, Nikolaos D ^b   Dougenis, Dimitrios ^b   Scopa, Chrisoula ^b   Papadaki, Helen ^b   Kalofonos, Haralabos P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Lung cancer; NF kB2; NSCLC; p52; RelB

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELB;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NF-KAPPA B; PROGNOSIS; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELB;

EID: 84863724084     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1230-2     Document Type: Article

References (30)

1. Miller YE (2005) Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol 33(3):216-223 (Pubitemid 41254287)
2. Aggarwal BB (2004) Nuclear factor-kappa-B: the enemy within. Cancer Cell 6(3):203-208
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225-249
4. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359(13):1367-1380
5. Sato M, Shames DS, Gazdar AF, Minna JD (2007) A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2(4):327-343 (Pubitemid 47181718)
6. May MJ, Ghosh S (1997) Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol 8(2):63-73. doi:10.1006/ scbi.1997.0057
7. Chen LF, Greene WC (2004) Shaping the nuclear action of NFkappaB. Nat Rev Mol Cell Biol 5(5):392-401. doi:10.1038/ nrm1368 nrm1368
8. Perkins ND (2007) Integrating cell-signalling pathways with NFkappaB and IKK function. Nat Rev Mol Cell Biol 8(1):49-62. doi:10.1038/nrm2083 (Pubitemid 46012014)
9. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132(3):344-362. doi:10.1016/j.cell.2008.01.020 (Pubitemid 351192002)
10. Karin M (2006) Nuclear factor-kappa B in cancer development and progression. Nature 441(7092):431-436. doi:10.1038/ Nature04870 (Pubitemid 44050137)
11. Grivennikov SI, Greten FR, KarinM(2010) Immunity, inflammation, and cancer. Cell 140(6):883-899. doi:10.1016/j.cell.2010.01.025
12. Okamoto T, Sanda T, Asamitsu K (2007) NF-kappa B signaling and carcinogenesis. Curr Pharm Des 13(5):447-462
13. Pacifico F, Leonardi A (2006) NF-kappa B in solid tumors. Biochem Pharmacol 72(9):1142-1152. doi:10.1016/j.bcp. 2006.07.032
14. Rayet B, Gelinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18(49):6938-6947
15. Tang X, Liu D, Shishodia S, Ozburn N, Behrens C, Lee JJ, Hong WK, Aggarwal BB,Wistuba II (2006) Nuclear factor-kappaB (NFkappaB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer 107(11):2637-2646. doi:10.1002/cncr.22315 (Pubitemid 44845619)
16. Zhang Z, Ma J, Li N, Sun N,Wang C (2006) Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer. Ann Thorac Surg 82(1):243-248. doi:10.1016/ j.athoracsur.2006.01.049
17. Zhang D, Jin X, Wang F, Wang S, Deng C, Gao Z, Guo C (2007) Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer. Ann Surg Oncol 14 (12):3581-3592. doi:10.1245/s10434-007-9560- z (Pubitemid 350160125)
18. Travis WD, World Health Organization, International Agency for Research on Cancer, International Association for the Study of Lung Cancer, International Academy of Pathology (2004) Pathology and genetics of tumours of the lung, pleura, thymus, and heart. IARC Press, Lyon
19. Taylor C (2006) Quantifiable internal reference standards for immunohistochemistry: the measurement of quantity by weight. Appl Immunohistochem Mol Morphol 14:253-259 (Pubitemid 44319049)
20. Wong ET, Tergaonkar V (2009) Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Clin Sci (Lond) 116(6):451-465. doi:10.1042/CS20080502
21. Dejardin E (2006) The alternative NF-kappa B pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem Pharmacol 72(9):1161-1179. doi:10.1016/j.bcp. 2006.08.007 (Pubitemid 44479741)
22. Lukashev M, LePage D, Wilson C, Bailly V, Garber E, Lukashin A, Ngam-ek A, Zeng W, Allaire N, Perrin S, Xu X, Szeliga K, Wortham K, Kelly R, Bottiglio C, Ding J, Griffith L, Heaney G, Silverio E, Yang W, Jarpe M, Fawell S, Reff M, Carmillo A, Miatkowski K, Amatucci J, Crowell T, Prentice H, Meier W, Violette SM, Mackay F, Yang D, Hoffman R, Browning JL (2006) Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy. Cancer Res 66(19):9617-9624. doi:10.1158/0008-5472.CAN-06-0217 (Pubitemid 44623661)
23. Ishikawa K, Miyamoto M, Yoshioka T, Kato T, Kaji M, Ohbuchi T, Hirano S, Itoh T, Dosaka-Akita H, Kondo S (2008) Upregulation of CD40 with juxtacrine activity in human nonsmall lung cancer cells correlates with poor prognosis. Cancer 113 (3):530-541. doi:10.1002/cncr.23618
24. Loskog AS, Eliopoulos AG (2009) The Janus faces of CD40 in cancer. Semin Immunol 21(5):301-307. doi:10.1016/j.smim.2009.07.001
25. Lessard L, Begin LR, Gleave ME, Mes-Masson AM, Saad F (2005) Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study. Br J Cancer 93(9):1019-1023. doi:10.1038/sj.bjc. 6602796 (Pubitemid 41548396)
26. Kang MR, Kim MS, Kim SS, Ahn CH, Yoo NJ, Lee SH (2009) NFkappaB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas. Pathology 41(7):622-625. doi:10.3109/00313020903257756
27. Liu X, Wang B, Ma X, Guo Y (2009) NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type. Jpn J Clin Oncol 39(7):418-424. doi:10.1093/jjco/hyp037
28. Chen F, Castranova V (2007) Nuclear factor-kappaB, an unappreciated tumor suppressor (Pubitemid 350248529)
29. Chen F, Beezhold K, Castranova V (2008) Tumor promoting or tumor suppressing of NF-kappa B, a matter of cell context dependency. Int Rev Immunol 27(4):183-204. doi:10.1080/08830180802130327 (Pubitemid 351896702)
30. Lessard L, Karakiewicz PI, Bellon-Gagnon P, Alam-Fahmy M, Ismail HA, Mes-Masson AM, Saad F (2006) Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases. Clin Cancer Res 12 (19):5741-5745. doi:10.1158/1078-0432.CCR-06-0330 (Pubitemid 44629604)